Rhine bio vs da an gene hot money and agency hype sample

Since entering June, the strong performance of the biopharmaceutical listed companies once again attracts the market eyeball.　　The Bio-agent unit, led by the Rhine, has surged in the week to 36.38% from May 31 to June 4, up 12.88% per cent in the same period.　　And from the exchange after the transaction of trading information can be seen, the Rhine biological and Da An genes represent the floating capital and the agency hype two different samples. A brokerage researcher told the newspaper reporter, the hot money is to choose No agency to participate in the target. Rhine Biology is a perfect standard, there is speculation concept, the circulation of small, coupled with no institutional funding concerns, easy to operate.　　And the operation of the hot money is also very fierce, once a fancy prey, adopt the technique is high change the hand of the force to pull up the market.　　Statistics show that the six trading days between May 31 and June 7, the Rhine biological turnover rate, 19.03%, 37.9%, 22.78%, 37.1%, 44.56%, 46.18%, the cumulative turnover rate of up to 207.55%. June 8, Rhine biological began to suspend the verification.　　And Da an gene after the face of profit return to vomit pressure, June 8 all day fell 4.58%, closed to 14.99 Yuan, June 9, then slightly rose to 15 yuan.　　Hot money speculation vs. the body of the speculation from the Rhine bio-trace can be seen, the famous hot money suicide camp State letter Securities Shenzhen, a nine-road securities business department will appear.　　June 7, Rhine biological trading day, the state letter of the securities of Shenzhen City Nine road securities business day to buy the first place, the whole day to buy the amount of 9.5593 million yuan, at the same time, the sales department also has some of the funds at high distribution, the sale amount of 6.7671 million yuan. Another main fund is the Citic Department's business department, respectively, CITIC Securities Shanghai Liyang Road Securities sales department and Citic Gold Tong Yiwu Chemical Road Securities Sales Department, the sale of the list.　　The purchase amount and the selling amount are 6.111 million yuan, 5.2568 million yuan and 9.7738 million yuan and 2.5308 million yuan respectively.　　In addition, the Shanghai Securities Wenzhou Sheich Mall Securities Business Department and the Bank of China International Dalian Huanghe Road Securities Business Department also appeared in the day of the main purchase list, the purchase amount is 5.8973 million yuan and 5.4 million yuan, two sales department of the day sold only 329800 yuan and 391,800 yuan. Can be seen, located in the Citic Department of the main business of the hot money is mainly pulling high shipments.　　On the day of the sale of the top is Citic Securities under the Citic Gold Tong Taizhou City Road Securities Business Department, the day sold up to 19.877 million yuan.　　Xin Securities Shanghai Nandan Road Securities Business Department and Haitong Securities Shenzhen branch Hua Fu Lu Securities Business Department is also one of the main selling day, the sale amount is 7.5337 million yuan and 6.9205 million yuan respectively. Statistics show that from June 3, 2010 to June 7, 2010, the Rhine biomass cumulative turnover of up to 80.75 million shares, the transaction amount of1,814,550,000 Yuan. From the top 5 sales department in the purchase amount, located in the Galaxy Securities Xiamen Lake Road Securities Business Department, CITIC Securities Shanghai Liyang Road, Everbright Securities Shenzhen Shennan Road, Citic Gold Tong Taizhou City Avenue, state Letter Securities Shenzhen, the nine Road securities business department, such as five of the hot money has become the Rhine bio-life recently soared the main force.　　Its buying amount is 31.8456 million yuan, 25.8054 million yuan, 21.162 million yuan, 19.5099 million yuan, 18.3954 million yuan respectively.　　However, in attracting more funds to follow suit, the above sales department has paid a lot of money, respectively, reached 33.4795 million yuan, 21.3435 million yuan, 21.9105 million yuan, 20.4 million yuan, 14.9531 million yuan.　　In addition, the Bohai Securities Shanghai Zhangwu Road Securities sales Office also appeared in the second, sell the amount amounted to 22.2896 million yuan, the corresponding purchase amount is 17.6414 million yuan, net sell 4.6482 million yuan. In contrast, with the hot money hype is different, the agency of the DA an gene hype is much milder. From June 3, 2010 to June 7, 2010, the gene accumulated 68.95 million shares, the cumulative turnover of 994.76 million yuan, respectively accounted for the Rhine biological volume and turnover of 85.38% and 54.82%.　　And the Da an Gene and Rhine biological circulation share capital of 230 million shares and 63.16 million shares respectively.　　Statistics show that in the meantime, the amount of gene buy in the top five sales department, the agency seats occupy two seats, net buy amount is 12.461 million yuan and 10.0453 million yuan respectively.　　Exaggerated securities researcher Zhao Cen said, in the pharmaceutical industry fundamentals continue to good premise, the biological industry development planning rules will be announced the expected, become the capital and institutional exaggerated main reasons.　　Hunan Financial Securities Institute researcher Ye Shi pointed out that Chengdu, Jiangsu, Shenzhen and other place in the second half of 2009 has been issued for the bio-pharmaceutical industry support policy, hope through special funds, discount loans, tax concessions and other means to cultivate a group of innovative pharmaceutical enterprises.　　Hengtai Securities analyst Li Xianyong pointed out that the Rhine is located in one of the largest plant resources in the province of Guangxi, is one of the most complete varieties of plant extracts of the enterprise, has mastered more than 200 kinds of plant extracts production technology.　　In addition, Guangxi is one of the largest plant resources provinces in China except Yunnan, the company's main varieties of arhat fruit, litchi peel, bitter orange, anise and other extracts of raw materials are local specialties in Guangxi, the company has the location of raw materials procurement advantages.　　And for the gene, Ye Shi said the current outbreak of hand-foot-mouth disease in China is a trigger for a stronger share price. "The company's hand-foot-mouth Disease PCR Diagnostic Kit is the exclusive product, will be expected to benefit." "Ye Shi said. "The product was listed last August and missed last year's high, so it will increase this yearLarger。 ”